Jacobs Levy Equity Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Sell |
53,318
-7
| -0% | -$52 | ﹤0.01% | 917 |
|
|
2025
Q1 | $459K | Buy |
53,325
+8,845
| +20% | +$76.1K | ﹤0.01% | 928 |
|
|
2024
Q4 | $1.59M | Buy |
44,480
+4,758
| +12% | +$170K | 0.01% | 644 |
|
|
2024
Q3 | $1.88M | Buy |
39,722
+20,298
| +104% | +$959K | 0.01% | 617 |
|
|
2024
Q2 | $976K | Sell |
19,424
-12,971
| -40% | -$652K | ﹤0.01% | 748 |
|
|
2024
Q1 | $3.63M | Sell |
32,395
-4,829
| -13% | -$541K | 0.02% | 487 |
|
|
2023
Q4 | $2.16M | Buy |
+37,224
| New | +$2.16M | 0.01% | 591 |
|
|
2023
Q2 | – | Sell |
-2,636
| Closed | -$271K | – | 1042 |
|
|
2023
Q1 | $271K | Sell |
2,636
-17,490
| -87% | -$1.8M | ﹤0.01% | 880 |
|
|
2022
Q4 | $2.95M | Buy |
20,126
+3,979
| +25% | +$583K | 0.02% | 481 |
|
|
2022
Q3 | $2.73M | Buy |
+16,147
| New | +$2.73M | 0.02% | 504 |
|
|
2019
Q4 | – | Sell |
-6,116
| Closed | -$242K | – | 1043 |
|
|
2019
Q3 | $242K | Sell |
6,116
-559
| -8% | -$22.1K | ﹤0.01% | 812 |
|
|
2019
Q2 | $676K | Buy |
+6,675
| New | +$676K | 0.01% | 701 |
|
|
2019
Q1 | – | Sell |
-1,547
| Closed | -$158K | – | 1004 |
|
|
2018
Q4 | $158K | Buy |
+1,547
| New | +$158K | ﹤0.01% | 911 |
|